{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:55Z","timestamp":1707525595554},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,13]]},"DOI":"10.7759\/cureus.50454","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T15:46:50Z","timestamp":1702482410000},"source":"Crossref","is-referenced-by-count":0,"title":["Niacin-Induced Syncope in a Middle-Aged Male: When an Over-the-Counter Vitamin Goes Wrong"],"prefix":"10.7759","author":[{"given":"Jiannan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodeji","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khizar","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.08.007","article-title":"Effect of extended-release niacin on plasma lipoprotein(a) levels: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"65","author":"Sahebkar A","year":"2016","unstructured":"Sahebkar A, Reiner \u017d, Simental-Mend\u00eda LE, Ferretti G, Cicero AF. Effect of extended-release niacin on plasma lipoprotein(a) levels: a systematic review and meta-analysis of randomized placebo-controlled trials. Metabolism. 2016, 65:1664-78. 10.1016\/j.metabol.2016.08.007","journal-title":"Metabolism"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(86)80293-5","article-title":"Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin","volume":"8","author":"Canner PL","year":"1986","unstructured":"Canner PL, Berge KG, Wenger NK, et al.. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986, 8:1245-55. 10.1016\/s0735-1097(86)80293-5","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.026","article-title":"Safety of niacin and simvastatin combination therapy","volume":"101","author":"Bays H","year":"2008","unstructured":"Bays H. Safety of niacin and simvastatin combination therapy. Am J Cardiol. 2008, 101:3B-8B. 10.1016\/j.amjcard.2008.02.026","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-4-3","article-title":"The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature","volume":"4","author":"Prousky J","year":"2005","unstructured":"Prousky J, Seely D. The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature. Nutr J. 2005, 4:3. 10.1186\/1475-2891-4-3","journal-title":"Nutr J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040631","article-title":"Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury","volume":"140","author":"DeFilippis AP","year":"2019","unstructured":"DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, Morrow DA. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 2019, 140:1661-78. 10.1161\/CIRCULATIONAHA.119.040631","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2018-207767","article-title":"Approach to syncope in the emergency department","volume":"36","author":"Reed MJ","year":"2019","unstructured":"Reed MJ. Approach to syncope in the emergency department. Emerg Med J. 2019, 36:108-16. 10.1136\/emermed-2018-207767","journal-title":"Emerg Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01528.x","article-title":"Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review","volume":"258","author":"Carlson LA","year":"2005","unstructured":"Carlson LA. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J Intern Med. 2005, 258:94-114. 10.1111\/j.1365-2796.2005.01528.x","journal-title":"J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.17226\/6015","article-title":"Other B vitamins and choline","author":"Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate","year":"1998","unstructured":"Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate. Other B vitamins and choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press, Washington DC, USA; 1998. 10.17226\/6015"},{"key":"ref9","unstructured":"U.S. Department of Agriculture. Agricultural Research Service. Nutrient intakes from food and beverages. mean amounts consumed per individual, by gender and age, what we eat in America, NHANES 2017-March 2020 prepandemic. (2022). Accessed: 3\/6\/2023: https:\/\/www.ars.usda.gov\/ARSUserFiles\/80400530\/pdf\/1720\/Table_1_NIN_GEN_1720.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3945\/jn.111.142257","article-title":"Foods, fortificants, and supplements: where do Americans get their nutrients?","volume":"141","author":"Fulgoni VL 3rd","year":"2011","unstructured":"Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements: where do Americans get their nutrients?. J Nutr. 2011, 141:1847-54. 10.3945\/jn.111.142257","journal-title":"J Nutr"},{"key":"ref11","unstructured":"NIH Dietary Supplement Label Database. Niacin. (2023). Accessed. 3\/6\/2023: https:\/\/dsld.od.nih.gov\/search\/niacin\/bWFya2V0X3N0YXR1cz1hbGwvZW50cnlfZGF0ZT0yMDExLDIwMjIvc29ydD1tYXRjaC9wYWdlX3NpemU...."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden WE","year":"2011","unstructured":"Boden WE, Probstfield JL, Anderson T, et al.. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011, 365:2255-67. 10.1056\/NEJMoa1107579","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray MJ","year":"2014","unstructured":"Landray MJ, Haynes R, Hopewell JC, et al.. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014, 371:203-12. 10.1056\/NEJMoa1300955","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1311039","article-title":"Safety profile of extended-release niacin in the AIM-HIGH trial","volume":"371","author":"Anderson TJ","year":"2014","unstructured":"Anderson TJ, Boden WE, Desvigne-Nickens P, Fleg JL, Kashyap ML, McBride R, Probstfield JL. Safety profile of extended-release niacin in the AIM-HIGH trial. N Engl J Med. 2014, 371:288-90. 10.1056\/NEJMc1311039","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0535","article-title":"A \"hot\" topic in dyslipidemia management--\"how to beat a flush\": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention","volume":"85","author":"Jacobson TA","year":"2010","unstructured":"Jacobson TA. A \"hot\" topic in dyslipidemia management--\"how to beat a flush\": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention. Mayo Clin Proc. 2010, 85:365-79. 10.4065\/mcp.2009.0535","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700586","article-title":"Langerhans cells release prostaglandin D2 in response to nicotinic acid","volume":"126","author":"Maciejewski-Lenoir D","year":"2006","unstructured":"Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol. 2006, 126:2637-46. 10.1038\/sj.jid.5700586","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Beny\u00f3 Z","year":"2005","unstructured":"Beny\u00f3 Z, Gille A, Kero J, et al.. GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest. 2005, 115:3634-40. 10.1172\/JCI23626","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy SM","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al.. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APHA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019, 139:e1082-143. 10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1406410","article-title":"Niacin and HDL cholesterol--time to face facts","volume":"371","author":"Lloyd-Jones DM","year":"2014","unstructured":"Lloyd-Jones DM. Niacin and HDL cholesterol--time to face facts. N Engl J Med. 2014, 371:271-3. 10.1056\/NEJMe1406410","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213381-niacin-induced-syncope-in-a-middle-aged-male-when-an-over-the-counter-vitamin-goes-wrong","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:34Z","timestamp":1707509374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213381-niacin-induced-syncope-in-a-middle-aged-male-when-an-over-the-counter-vitamin-goes-wrong"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.50454","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,13]]}}}